News Conference News EuroPCR 2016 Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices Michael O'Riordan May 23, 2016
News Conference News EuroPCR 2016 Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You? Yael L. Maxwell May 20, 2016
News Conference News EuroPCR 2016 ‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices Caitlin E. Cox May 17, 2016
News Conference News ACC 2016 Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes Michael O'Riordan April 07, 2016
News Conference News ACC 2016 Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients L.A. McKeown April 04, 2016
News Conference News ACC 2016 TAVR Mortality Declines as Volumes Increase: So How Many US Centers Are Enough? Shelley Wood April 03, 2016
News Conference News ACC 2016 Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial Yael L. Maxwell April 03, 2016
News Conference News ACC 2016 When Chosen Wisely, 90-Year-Olds Do Well After TAVR Caitlin E. Cox April 02, 2016
News Conference News ACC 2016 TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral Shelley Wood April 02, 2016
News Conference News CRT 2016 Early Results for Transcatheter Mitral Valve Replacement Reveal Complications and Challenges for the Long Road Ahead Shelley Wood February 21, 2016
News Conference News TCT 2015 Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves Todd Neale October 15, 2015
News Conference News TCT 2015 Low 1-Year Event Rates Seen After TAVR With Sapien 3 Todd Neale October 15, 2015
News Conference News TCT 2015 Global TAVR Market Poised to Exceed DES Market by 2025 October 11, 2015
News Conference News TCT 2015 Asian TAVR Registry Shows Good Procedural and Clinical Results October 11, 2015
News Conference News EuroPCR 2015 New, Old CoreValve Iterations Showing Reductions in Pacemaker Need, Paravalvular Leak Yael L. Maxwell May 22, 2015
News Conference News EuroPCR 2015 Sapien 3 Experience in Europe, Canada Shows Low Mortality, Paravalvular Leak at 30 Days Yael L. Maxwell May 21, 2015
News Conference News ACC 2015 ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted Todd Neale March 20, 2015
News Conference News ACC 2015 DEFLECT III: TAVR Neuroprotection Device Safely Reduces Lesion Volume Yael L. Maxwell March 16, 2015
News Conference News ACC 2015 Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR Yael L. Maxwell March 15, 2015
News Conference News ACC 2015 Follow-up TAVR Studies Reassure About Valve Durability, Outcomes Todd Neale March 15, 2015